Skip to main content
OpenTrials
Completed

NCT Number: NCT04927078

Analysis of Vital Signs in Patients With COVID-19

This project will use data obtained from a proprietary vision-based patient monitoring and management system (OxeVision) for measuring heart rate and respiratory rate which is in clinical use at the Coventry and Warwickshire Partnership NHS Trust.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Respiratory Disease COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiration Disorders Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Coventry and Warwickshire Partnership NHS

Coventry, United Kingdom

About this study

The investigators will analyse data from patients with known COVID 19 infection both during, and where possible before clinical COVID 19 infection and controls to determine whether changes can be detected in these parameters that precede overt clinical deterioration. The role of remote vision-based patient monitoring and management in supporting the care of patients with COVID-19 will be assessed through staff interviews.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients age 18 and above. Patients on wards with a medical diagnosis of COVID 19 who are in rooms with the Vision based patient monitoring and management system.

Exclusion criteria

Children will be excluded. No data will be excluded unless specifically requested by the treating clinician.

Treatment and study plan

Observation of breathing pattern

Other

Observations will be collected using a remote vision based patient monitoring and management system.

Primary outcomes

  1. Breathing rates

    Time frame: Data will be collected throughout study completion, an average of 7 months, to obtain breathing rate before and after the diagnosis of COVID 19.

    Breathing rates collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.

Secondary outcomes

  1. Pulse rates

    Time frame: Data will be collected throughout study completion, an average of 7 months, to obtain pulse rate before and after the diagnosis of COVID 19.

    Pulse rate collected via remote monitoring of participants using the Vision Based Patient Monitoring and Management System.

  2. BR and PR

    Time frame: Data will be collected throughout study completion, an average of 7 months, to obtain breathing and pulse rate before and after the diagnosis of COVID 19.

    Similar data to be collected from control subjects

Sponsors and collaborators

Lead sponsor

Oxehealth Limited

Industry

Collaborators

  • Royal Brompton & Harefield NHS Foundation Trust

Registry information

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 15, 2021
Registry last updated
Jun 15, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.